Richard Klausner - Net Worth and Insider Trading
Richard Klausner Net Worth
The estimated net worth of Richard Klausner is at least $76 Million dollars as of 2024-05-10. Richard Klausner is the Director of Juno Therapeutics Inc and owns about 728,775 shares of Juno Therapeutics Inc (JUNO) stock worth over $63 Million. Richard Klausner is the Director of Lyell Immunopharma Inc and owns about 3,898,714 shares of Lyell Immunopharma Inc (LYEL) stock worth over $10 Million. Richard Klausner is also the Sr VP, Chief Medical Officer of Illumina Inc and owns about 23,100 shares of Illumina Inc (ILMN) stock worth over $3 Million. Details can be seen in Richard Klausner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Klausner has not made any transactions after 2023-08-15 and currently still holds the listed stock(s).
Transaction Summary of Richard Klausner
Richard Klausner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Klausner owns 3 companies in total, including Juno Therapeutics Inc (JUNO) , Illumina Inc (ILMN) , and Lyell Immunopharma Inc (LYEL) .
Click here to see the complete history of Richard Klausner’s form 4 insider trades.
Insider Ownership Summary of Richard Klausner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JUNO | Juno Therapeutics Inc | 2018-03-05 | director |
| ILMN | Illumina Inc | 2015-11-13 | Sr VP & Chief Medical Officer |
| LYEL | Lyell Immunopharma Inc | 2023-08-15 | director & Executive Chairman |
Richard Klausner Latest Holdings Summary
Richard Klausner currently owns a total of 3 stocks. Among these stocks, Richard Klausner owns 728,775 shares of Juno Therapeutics Inc (JUNO) as of January 8, 2018, with a value of $63 Million and a weighting of 82.91%. Richard Klausner owns 3,898,714 shares of Lyell Immunopharma Inc (LYEL) as of August 15, 2023, with a value of $10 Million and a weighting of 13.72%. Richard Klausner also owns 23,100 shares of Illumina Inc (ILMN) as of November 13, 2015, with a value of $3 Million and a weighting of 3.37%.
Latest Holdings of Richard Klausner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JUNO | Juno Therapeutics Inc | 2018-01-08 | 728,775 | 86.96 | 63,374,274 |
| LYEL | Lyell Immunopharma Inc | 2023-08-15 | 3,898,714 | 2.69 | 10,487,541 |
| ILMN | Illumina Inc | 2015-11-13 | 23,100 | 111.35 | 2,572,185 |
Holding Weightings of Richard Klausner
Richard Klausner Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Klausner has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 12,724 shares on January 8, 2018, which brought Richard Klausner around $613,424.
According to the SEC Form 4 filings, Richard Klausner has made a total of 2 transactions in Lyell Immunopharma Inc (LYEL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Lyell Immunopharma Inc is the sale of 58,020 shares on August 15, 2023, which brought Richard Klausner around $132,286.
According to the SEC Form 4 filings, Richard Klausner has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 730 shares on November 13, 2015, which brought Richard Klausner around $119,370.
Insider Trading History of Richard Klausner
- 1
Richard Klausner Trading Performance
Richard Klausner Ownership Network
Richard Klausner Owned Company Details
What does Juno Therapeutics Inc do?
Who are the key executives at Juno Therapeutics Inc?
Richard Klausner is the director of Juno Therapeutics Inc. Other key executives at Juno Therapeutics Inc include director & CEO & President Hans Edgar Bishop , 10 percent owner Celgene Corp /de/ , and 10 percent owner Celgene Switzerland Llc .
Juno Therapeutics Inc (JUNO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Juno Therapeutics Inc (JUNO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Juno Therapeutics Inc (JUNO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Juno Therapeutics Inc (JUNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Juno Therapeutics Inc Insider Transactions
Richard Klausner Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Klausner. You might contact Richard Klausner via mailing address: 5200 Illumina Way, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
